Evidence mapPaperPMID 32284705Full record

ArticleAn international journal on information fusion2020

Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning.

Diego Castillo-Barnes, Li Su, Javier Ramírez, Diego Salas-Gonzalez, Francisco J Martinez-Murcia, Ignacio A Illan, Fermin Segovia, Andres Ortiz, Carlos Cruchaga, Martin R Farlow and 10 more

Abstract read
In one paragraph

Article in An international journal on information fusion, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Frontiers in aging neuroscience · 2021
    Article
  10. Radiomics Features PredictFrontiers in oncology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Diego Castillo-BarnesDepartment of Signal Theory, Telematics and Communications, University of Granada, Granada (Spain).
Li SuDepartment of Psychiatry, University of Cambridge, Cambridge (UK).
Javier RamírezDepartment of Signal Theory, Telematics and Communications, University of Granada, Granada (Spain).
Diego Salas-GonzalezDepartment of Signal Theory, Telematics and Communications, University of Granada, Granada (Spain).
Francisco J Martinez-MurciaDepartment of Communications Engineering, University of Malaga, Malaga (Spain).
Ignacio A IllanDepartment of Signal Theory, Telematics and Communications, University of Granada, Granada (Spain).
Fermin SegoviaDepartment of Signal Theory, Telematics and Communications, University of Granada, Granada (Spain).
Andres OrtizDepartment of Communications Engineering, University of Malaga, Malaga (Spain).
Carlos CruchagaDepartment of Psychiatry and Neurology, Washington University School of Medicine, St. Louis, Missouri (USA).
Martin R FarlowDepartment of Neurology, Indiana University School of Medicine, Indianapolis, Indiana (USA).
Chengjie XiongDivision of Biostatistics, Washington University School of Medicine, St. Louis, Missouri (USA).
Neil R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, Florida (USA).
Peter R SchofieldNeuroscience Research Australia and School of Medical Sciences, University of New South Wales, Sydney (Australia).
Colin L MastersFlorey Institute and University of Melbourne, Victoria (Australia).
Stephen SallowayButler Hospital, Rhode Island (USA).
Mathias JuckerDepartment of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen (Germany).
Hiroshi MoriDepartment of Clinical Neuroscience, Osaka City University Medical school, Osaka (Japan).
Johannes LevinDepartment of Neurology, Ludwig-Maximilians-University of Munich, Munich (Germany).
Juan M GorrizDepartment of Signal Theory, Telematics and Communications, University of Granada, Granada (Spain).
Dominantly Inherited Alzheimer Network (DIAN)

Funding

Imaging CoreU19AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2010 to 2025
$53.9M
Genetic Architecture of Alzheimer’s disease ProteinopathiesR01AG064877 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CRUCHAGA, CARLOS, KAMBOH, M. ILYAS · 2021 to 2024
$8.4M
USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITSRF1AG053303 · NIA · WASHINGTON UNIVERSITY · PI CLIMER, SHARLEE, CRUCHAGA, CARLOS · 2016 to 2020
$4.0M
Identifying Rare Variants that Increase Risk for Alzheimer's DiseaseRF1AG044546 · NIA · WASHINGTON UNIVERSITY · PI CRUCHAGA, CARLOS · 2019 to 2019
$3.6M
GENETIC MODIFIERS OF CEREBROSPINAL FLUID TREM2 IN ALZHEIMER'S DISEASERF1AG058501 · NIA · WASHINGTON UNIVERSITY · PI CRUCHAGA, CARLOS, PICCIO, LAURA · 2018 to 2018
$3.5M
The Familial Alzheimer Sequencing (FASe) ProjectU01AG058922 · NIA · WASHINGTON UNIVERSITY · PI CRUCHAGA, CARLOS, GOATE, ALISON M · 2018 to 2022
$3.5M
NIA NIH HHS R01 AG064877NIA NIH HHS RF1 AG044546NIA NIH HHS RF1 AG053303NIA NIH HHS RF1 AG058501NIA NIH HHS U01 AG058922NIA NIH HHS U19 AG032438
6 · The paper itself

Abstract

Despite subjects with Dominantly-Inherited Alzheimer's Disease (DIAD) represent less than 1% of all Alzheimer's Disease (AD) cases, the Dominantly Inherited Alzheimer Network (DIAN) initiative constitutes a strong impact in the understanding of AD disease course with special emphasis on the presyptomatic disease phase. Until now, the 3 genes involved in DIAD pathogenesis (PSEN1, PSEN2 and APP) have been commonly merged into one group (Mutation Carriers, MC) and studied using conventional statistical analysis. Comparisons between groups using null-hypothesis testing or longitudinal regression procedures, such as the linear-mixed-effects models, have been assessed in the extant literature. Within this context, the work presented here performs a comparison between different groups of subjects by considering the 3 genes, either jointly or separately, and using tools based on Machine Learning (ML). This involves a feature selection step which makes use of ANOVA followed by Principal Component Analysis (PCA) to determine which features would be realiable for further comparison purposes. Then, the selected predictors are classified using a Support-Vector-Machine (SVM) in a nested k-Fold cross-validation resulting in maximum classification rates of 72-74% using PiB PET features, specially when comparing asymptomatic Non-Carriers (NC) subjects with asymptomatic PSEN1 Mutation-Carriers (PSEN1-MC). Results obtained from these experiments led to the idea that PSEN1-MC might be considered as a mixture of two different subgroups including: a first group whose patterns were very close to NC subjects, and a second group much more different in terms of imaging patterns. Thus, using a k-Means clustering algorithm it was determined both subgroups and a new classification scenario was conducted to validate this process. The comparison between each subgroup

Indexed as

Alzheimer’s Disease (AD)DIANDominantly-Inherited Alzheimer’s Disease (DIAD)Machine LearningNeuroimaging

Identifiers

PMID32284705
PMCPMC7153760

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.